Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors - Concepedia

Concepedia

Publication | Open Access

Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors

DOI Full Paper Access

58

Citations

44

References

2021

Year

Jian‐Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, Ina Becker, Sandra Rutzner, Markus Eckstein, Roger Sun, Hu Ma, Philipp Schubert, Claudia Schweizer,

Journal for ImmunoTherapy of Cancer

Abstract

NCT03453892.

References

	Year	Citations

Page 1